Lataa...
The development of proteinase-activated receptor-2 modulators and the challenges involved
Protease-activated receptor-2 (PAR2) has been extensively studied since its discovery in the mid-1990. Despite the advances in understanding PAR2 pharmacology, it has taken almost 25 years for the first inhibitor to reach clinical trials, and so far, no PAR2 antagonist has been approved for human us...
Tallennettuna:
| Julkaisussa: | Biochem Soc Trans |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Portland Press Ltd.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7752072/ https://ncbi.nlm.nih.gov/pubmed/33242065 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BST20200191 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|